RFG Advisory’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-5,576
| Closed | -$239K | – | 722 |
|
|
2024
Q1 | $239K | Sell |
5,576
-96
| -2% | -$4.12K | 0.01% | 653 |
|
|
2023
Q4 | $210K | Sell |
5,672
-401
| -7% | -$14.9K | 0.01% | 627 |
|
|
2023
Q3 | $220K | Sell |
6,073
-18
| -0.3% | -$652 | 0.01% | 579 |
|
|
2023
Q2 | $217K | Buy |
6,091
+32
| +0.5% | +$1.14K | 0.01% | 591 |
|
|
2023
Q1 | $216K | Sell |
6,059
-506
| -8% | -$18K | 0.01% | 584 |
|
|
2022
Q4 | $229K | Sell |
6,565
-5,461
| -45% | -$190K | 0.01% | 566 |
|
|
2022
Q3 | $387K | Buy |
12,026
+1,766
| +17% | +$56.8K | 0.02% | 430 |
|
|
2022
Q2 | $520K | Buy |
10,260
+6,066
| +145% | +$307K | 0.03% | 348 |
|
|
2022
Q1 | $228K | Sell |
4,194
-270
| -6% | -$14.7K | 0.01% | 465 |
|
|
2021
Q4 | $246K | Buy |
+4,464
| New | +$246K | 0.02% | 425 |
|
|
2017
Q2 | – | Sell |
-11,943
| Closed | -$626K | – | 135 |
|
|
2017
Q1 | $626K | Buy |
11,943
+5,773
| +94% | +$303K | 0.47% | 49 |
|
|
2016
Q4 | $335K | Hold |
6,170
| – | – | 0.32% | 64 |
|
|
2016
Q3 | $334K | Buy |
6,170
+14
| +0.2% | +$758 | 0.31% | 65 |
|
|
2016
Q2 | $334K | Buy |
6,156
+239
| +4% | +$13K | 0.29% | 66 |
|
|
2016
Q1 | $300K | Buy |
5,917
+955
| +19% | +$48.4K | 0.23% | 72 |
|
|
2015
Q4 | $250K | Buy |
4,962
+648
| +15% | +$32.6K | 0.18% | 45 |
|
|
2015
Q3 | $207K | Sell |
4,314
-88
| -2% | -$4.22K | 0.67% | 50 |
|
|
2015
Q2 | $229K | Buy |
+4,402
| New | +$229K | 0.1% | 140 |
|